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Background:  Increased levels of high density lipoprotein cholesterol (HDL-C) are protective for coronary heart disease (CHD); however, the 
impact of inflammation on this association is not established. Our purpose is to evaluate if inflammation, measured by C-reactive protein (CRP), will 
attenuate the inverse association of HDL-C with CHD.
Methods:  We studied 5,867 men and women (weighted to 658 million) aged ≥18 years, without CHD at baseline, who participated in the National 
Health and Nutrition Examination Survey III from 1988-1994. Mortality was recorded by the National Death Index through 2006, mean follow-up was 
14.0 years. Groups were categorized by low (<40 mg/dL), intermediate (40-59 mg/dL), and high (≥60 mg/dL) HDL-C, and low (≤3 mg/L) or high (>3 
mg/L) CRP levels, and evaluated for CHD death using multivariable Cox regression adjusted for age, gender, race, low density lipoprotein-cholesterol, 
smoking, diabetes, body mass index, systolic blood pressure and triglycerides.
Results:  Using high HDL-C/low CRP as the reference, those with high HDL-C/high CRP had 2.0 times the risk of CHD death (95% CI 0.9-4.4) and 
those with low HDL/high CRP had 3.0 times the risk (95% CI 1.3-6.8) [Figure].
Conclusion: High CRP not only attenuates the protective effects of high HDL-C on CHD risk, but the increased risk associated with low HDL-C is 
seen only when CRP is high and is absent when CRP is normal. These results support the value of CRP measurement in CHD risk stratification as 
related to HDL-C measurements.
